质子重离子放射治疗在腹膜后肉瘤治疗中的价值
收稿日期: 2022-10-08
网络出版日期: 2023-01-30
基金资助
上海市卫生健康委员会科研项目(202140028);上海市卫生健康委员会科研项目(20224Y0273);上海市浦东新区卫生健康委员会卫生计生科研项目(PW2021A-41)
Value of proton and heavy ion radiotherapy in treatment of retroperitoneal sarcoma
王征, 包慈航, 蒋国梁 . 质子重离子放射治疗在腹膜后肉瘤治疗中的价值[J]. 外科理论与实践, 2022 , 27(06) : 506 -510 . DOI: 10.16139/j.1007-9610.2022.06.05
| [1] | Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database[J]. Lancet Oncol, 2016, 17(7):966-975. |
| [2] | Haas RLM, Bonvalot S, Miceli R, et al. Radiotherapy for retroperitoneal liposarcoma: a report from the Transatlantic Retroperitoneal Sarcoma Working Group[J]. Cancer, 2019, 125(8):1290-1300. |
| [3] | Bonvalot S, Gronchi A, Le Péchoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2020, 21(10):1366-1377. |
| [4] | Callegaro D, Raut CP, Ajayi T, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) versus off-trial (STREXIT) results[J]. Ann Surg, 2022.[2022-10-08]. https://europepmc.org/article/MED/35833413. |
| [5] | Joung RHS, Wayne JD. Contemporary multimodal management of primary retroperitoneal sarcomas[J]. Adv Oncol, 2022, 2(1):63-69. |
| [6] | Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution[J]. Ann Surg, 1998, 228(3):355-365. |
| [7] | Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2021, 32(11):1348-1365. |
| [8] | Allignet B, Sunyach MP, Geets X, et al. Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review[J]. Acta Oncol, 2022, 61(6):720-729. |
| [9] | Salerno KE, Baldini EH. Role of radiation therapy in retroperitoneal sarcoma[J]. J Natl Compr Canc Netw, 2022, 20(7):845-849. |
| [10] | Dinges S, Budach V, Budach W, et al. Local recurrences of soft tissue sarcomas in adults: a retrospective analysis of prognostic factors in 102 cases after surgery and radiation therapy[J]. Eur J Cancer, 1994, 30A(11):1636-1642. |
| [11] | Kepka L, DeLaney TF, Suit HD, et al. Results of radiation therapy for unresected soft-tissue sarcomas[J]. Int J Radiat Oncol Biol Phys, 2005, 63(3):852-859. |
| [12] | DeLaney TF, Haas RL. Innovative radiotherapy of sarcoma: proton beam radiation[J]. Eur J Cancer, 2016, 62:112-123. |
| [13] | von Mehren M, Kane JM, Agulnik M, et al. Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(7):815-833. |
| [14] | Swanson EL, Indelicato DJ, Louis D, et al. Comparison of three-dimensional(3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas[J]. Int J Radiat Oncol Biol Phys, 2012, 83(5):1549-1557. |
| [15] | Chung C, Trofimov A, Adams J, et al. Comparison of 3D conformal proton therapy, intensity-modulated proton therapy, and intensity-modulated photon therapy for retroperitoneal sarcoma[J]. Sarcoma, 2022, 2022:5540615. |
| [16] | Schneider RA, Vitolo V, Albertini F, et al. Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms[J]. Strahlenther Onkol, 2013, 189(12):1020-1025. |
| [17] | Yoon SS, Chen YL, Kirsch DG, et al. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas[J]. Ann Surg Oncol, 2010, 17(6):1515-1529. |
| [18] | DeLaney TF, Chen YL, Baldini EH, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas[J]. Adv Radiat Oncol, 2017, 2(1):85-93. |
| [19] | Minohara S, Fukuda S, Kanematsu N, et al. Recent innovations in carbon-ion radiotherapy[J]. J Radiat Res, 2010, 51(4):385-392. |
| [20] | Kamada T, Tsujii H, Blakely EA, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience[J]. Lancet Oncol, 2015, 16(2):e93-e100. |
| [21] | Durante M, Yamada S, Ando K, et al. X-rays vs. carbo-nion tumor therapy: cytogenetic damage in lymphocytes[J]. Int J Radiat Oncol Biol Phys, 2000, 47(3):793-798. |
| [22] | Spina CS, Tsuruoka C, Mao W, et al. Differential immune modulation with carbon-ion versus photon therapy[J]. Int J Radiat Oncol Biol Phys, 2021, 109(3):813-818. |
| [23] | Ming X, Wang W, Shahnazi K, et al. Dosimetric compa-rison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy[J]. Int J Radiat Biol, 2022, 98(2):183-190. |
| [24] | Seidensaal K, Kieser M, Hommertgen A, et al. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase Ⅱpilot trial[J]. Trials, 2021, 22(1):134. |
| [25] | Serizawa I, Kagei K, Kamada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas[J]. Int J Radiat Oncol Biol Phys, 2009, 75(4):1105-1110. |
| [26] | Imai R, Kamada T, Araki N, et al. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma[J]. Cancer Med, 2018, 7(9):4308-4314. |
/
| 〈 |
|
〉 |
